GHP Investment Advisors Inc. lessened its position in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 9.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,954 shares of the medical instruments supplier’s stock after selling 1,881 shares during the quarter. GHP Investment Advisors Inc.’s holdings in West Pharmaceutical Services were worth $1,772,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in WST. Captrust Financial Advisors acquired a new stake in shares of West Pharmaceutical Services during the 4th quarter worth approximately $125,000. Private Advisor Group LLC acquired a new stake in shares of West Pharmaceutical Services during the 3rd quarter worth approximately $202,000. Alps Advisors Inc. acquired a new stake in shares of West Pharmaceutical Services during the 4th quarter worth approximately $206,000. Tiedemann Wealth Management LLC acquired a new stake in shares of West Pharmaceutical Services during the 3rd quarter worth approximately $207,000. Finally, Stephens Inc. AR acquired a new stake in shares of West Pharmaceutical Services during the 3rd quarter worth approximately $210,000. 94.37% of the stock is currently owned by institutional investors.
Shares of West Pharmaceutical Services Inc. (NYSE:WST) opened at $92.07 on Wednesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.66 and a quick ratio of 1.89. The company has a market capitalization of $6,807.50, a price-to-earnings ratio of 46.27, a P/E/G ratio of 2.34 and a beta of 1.15. West Pharmaceutical Services Inc. has a one year low of $77.97 and a one year high of $103.36.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 2nd. Investors of record on Wednesday, April 18th will be paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend is Tuesday, April 17th. West Pharmaceutical Services’s dividend payout ratio is 28.14%.
West Pharmaceutical Services announced that its Board of Directors has approved a stock buyback plan on Thursday, February 15th that authorizes the company to repurchase 800,000 outstanding shares. This repurchase authorization authorizes the medical instruments supplier to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
Several brokerages have recently weighed in on WST. Zacks Investment Research raised West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $115.00 price objective on the stock in a report on Saturday, February 3rd. Goldman Sachs Group began coverage on West Pharmaceutical Services in a report on Wednesday, January 24th. They set a “neutral” rating and a $110.00 price objective on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. West Pharmaceutical Services currently has an average rating of “Hold” and a consensus price target of $108.17.
COPYRIGHT VIOLATION NOTICE: This story was first published by American Banking News and is owned by of American Banking News. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/03/14/ghp-investment-advisors-inc-sells-1881-shares-of-west-pharmaceutical-services-inc-wst.html.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.